WallStreetZenWallStreetZen

NYSE: SOLV
Solventum Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Solventum earnings were $379.0M for the trailing 12 months ending Mar 31, 2025, with -70.8% growth year over year. The latest SOLV earnings report on Mar 31, 2025 announced Q1 2025 earnings of $137.0M, up 341.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SOLV reported annual earnings of $479.0M, with -64.4% growth.

SOLV past earnings growth

How has SOLV's earnings growth performed historically?

Company
-70.78%
Industry
19.96%
Market
30.19%
SOLV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SOLV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SOLV earnings history

Current Revenue
$8.3B
Current Earnings
$379.0M
Current Profit Margin
4.6%

SOLV Return on Equity

Current Company
12.3%
Current Industry
9.9%
Current Market
31.3%
SOLV's Return on Equity (12.3%)... subscribe to Premium to read more.
High Return on Equity Performance

SOLV undefined

Current Company
2.6%
Current Industry
5.2%
SOLV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SOLV announces earnings.

SOLV undefined

Current Company
6.25%
Current Industry
9.3%

SOLV vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SOLV$1.29B$379.00M-70.78%$2.18
DOCS$276.07M$223.19M+49.38%$1.19
HQY$379.70M$121.81M+168.67%$1.40
WAY$375.33M$85.95MN/A$0.53
HNGEN/AN/AN/AN/A
View Top Health Information Service Stocks

Solventum Earnings Reports & History FAQ

What were Solventum's earnings last quarter?

Solventum (NYSE: SOLV) reported Q1 2025 earnings per share (EPS) of $0.79, up 42.34% year over year. Total SOLV earnings for the quarter were $137.00 million. In the same quarter last year, Solventum's earnings per share (EPS) was $1.37.

If you're new to stock investing, here's how to buy Solventum stock.

Is Solventum profitable or losing money?

As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $379.00 million, a 70.62% decrease year over year.

What was SOLV's earnings growth in the past year?

As of Solventum's earnings date in Q3 2025, Solventum's earnings has grown -70.78% year over year. This is 90.73 percentage points lower than the US Health Information Services industry earnings growth rate of 19.96%. SOLV earnings in the past year totalled $379.00 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.